Supplemental Table 5

Sep 09, 2014

10 likes | 96 Views

Supplemental Table 5.

Share Presentation

Embed Code

Link

supplemental table 5

arav

Download Presentation

Supplemental Table 5

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplemental Table 5

Supplemental Table : Information of primers

Supplemental Table : Information of primers.

144 views • 1 slides

Supplemental Table 1 .

Gross ER Page 31. Supplemental Table 1 . Supplemental Fig. 1. Gross ER Page 32. a. b . AAR/LV%. AAR/LV%. TAT + Incision. ↓ e PKC. ↓ e PKC + Incision. TAT. ↓ e PKC + Bradykinin. ↑ e PKC. Control. Bradykinin. Incision. c. AAR/LV%. ↓ g PKC + Incision. ↓ g PKC +

138 views • 5 slides

Supplemental Figure 5

Supplemental Figure 5. A. MTLn3 GFP-CXCL12. MTLn3 GFP-pQCXIP. C. B. ***. CXCR4. IgG. % of max. BMM Chemotaxis to CXCL12. % of max. CXCR4-PE. CXCR4-PE. IgG. CXCR4. B.

118 views • 1 slides

Supplemental Table 1

Patient Cohort Cardiac Disease Burden. Abbreviations: CCS – Coronary calcium score NYHA – New York heart association heart failure classification ACS – Acute coronary syndrome at the time of BM harvest CAD – Coronary artery disease ASD – Atrial septal defect (patent foramen ovale).

132 views • 3 slides

Supplemental Table S1

Supplemental Table S1. For Site Directed Mutagenesis and cloning of constructs P9GF: 5’ GAC GCT ACT TCA CTA TAG ATA GGA AGT TCA TTT C 3’ P9GR: 5’ GAA ATG AAC TTC CTA TCT ATA GTG AAG TAG CGT C 3’ LAP9GF: 5’ CCC GGA TCC ATC ACT ATA GAT AGG AAG TTC ATT TCA TTT G 3’

251 views • 3 slides

Supplemental Table 1

Supplemental Table 1.

75 views • 1 slides

Supplemental Figure 5

Trastuzumab-treated. Control-treated. A. MDA-MB-453. 14.2%. 10.7%. DEAB-inhibited. DEAB-inhibited. B. JIMT-1. 5.2%. 5.4%. DEAB-inhibited. DEAB-inhibited. C. Sum159-HER2. 7.1%. 36%. DEAB-inhibited. DEAB-inhibited. Trastuzumab-treated. Control-treated. D. Supplemental Figure 5.

134 views • 1 slides

Footnotes – Supplemental Table S3

Supplemental Table S3. Uncharacterized Genomic Regions Identified from Identical, Unique Phenobarbital (PB)-induced RAMs that Formed in Both CAR Wildtype, on a C3H/He Background (Precancerous Liver and/or Liver Tumors), and B6C3F1 (2 and/or 4 Week Treated Liver Tissue) Mice a.

135 views • 2 slides

Supplemental Table 2

Supplemental Table 2.

80 views • 1 slides

Supplemental File 1, Table 1s

Supplemental File 1, Table 1s. Supplemental File 2, Figure 2s. A. B. 0. 100. Supplemental File 3, Table 2s.

100 views • 3 slides

Supplemental Table S1

Supplemental Table S1. Table S1. Quantitative real-time RT-PCR primer sequences for genes used in the publication. All sequences are listed in the 5’ – 3’ direction. Supplemental Fig. S1. Induced by E2 and IGF-I. 3hr. 24hr. Repressed by E2 and IGF-I. 3hr. 24hr.

144 views • 4 slides

Supplemental Table 1: Receptor Status

Supplemental Table 1: Receptor Status. 131 genes List. (1) Expression Analysis. ③ 131 genes which were differential ly express ed between IBC and nIBC. Table. List of 99 genes expressed at higher levels in IBC. (1) Expression Analysis.

182 views • 7 slides

Online Supplemental Table

Online Supplemental Table. Online Supplemental Figures. I. I. I. M. M. sirius red. H.E. I. I. M. M. HHF35 (SMC). CD68 (M  ). II. I. I. M. M. PEDF. non-immune IgG. I. PEDF. M. Legend for online supplemental figures.

143 views • 4 slides

Supplemental Digital Content 3 – Table 2

Supplemental Digital Content 3 – Table 2. Suppl. Table 2. The number and percentage of drug-resistant mutations in patients.

140 views • 1 slides

Supplemental table 1

Supplemental table 1.

95 views • 1 slides

Supplemental Figure 5

Supplemental Figure 5.

69 views • 1 slides

Supplemental Figure 5

Supplemental Figure 5. p <0.05. p =0.05. a. b. p <0.05. p <0.05. p <0.05. p <0.05. c. Muscle. d. Liver. + - + - UCP3. p <0.01. UCP3. SDH. p <0.05.

84 views • 1 slides

Supplemental table 2

Supplemental table 2.

115 views • 1 slides

Supplemental Table 1

Supplemental Table 1. Name. Sequence. NH0004 5’-GTGATACTTGTGGGCCAG-3’ (antisense). NH0047 5’-TTTAAGCTTGTGCATCTGACTCCTGAGGAG-3’ (sense). NH0048 5’-TTTCTGCAGAAGCAAGAGAACTGAGTGGAG-3’ (antisense). NH0089 5’-CGGCGAGGCGTCGACCTCAAGTCCAAGACGTTC-3’ (sense).

184 views • 1 slides

Supplemental Table S1

Supplemental Table S1. Complete list of LC-MS myc interating protiens in the MCF7 cells, proteins highlighted in red are those differentially expressed from the LCC1 and LCC1 EGF treated cells. Supplemental Table S2.

150 views • 4 slides

Supplemental Table S1. (Continued)

Supplemental Table S1. Up-regulated Genes in OsCc1:AP37 and OsCc1:AP59 Plants in Comparison to Nontransgenic Controls. Supplemental Table S1. (Continued).

99 views • 7 slides

Supplemental Table S1

55 views • 4 slides

More Related